Avid Bioservices Inc (CDMO)

[bfiest]

Avid should be incorporating AI if they want to stay ahead of the curve. CDMOs that embrace AI technologies and foster a culture of innovation are likely to gain a competitive edge in this rapidly evolving landscape. It only makes sense from manufacturing optimization, quality assurance and compliance and accelerated drug discovery standpoints. Go big or go home. Let’s see if they unveil their future plans at the next meeting. It is definitely material information.